Search Results - Matthes, Steve

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer

    Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer by NIETO, Yago, VREDENBURGH, James J, JONES, Roy B, SHPALL, Elizabeth J, BEARMAN, Scott I, MCSWEENEY, Peter A, CHAO, Nelson, RIZZIERI, David, GASPARETTO, Christina, MATTHES, Steve, BARON, Anna E

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase II Trial of High-Dose Chemotherapy with Autologous Stem Cell Transplant for Stage IV Breast Cancer with Minimal Metastatic Disease

    Phase II Trial of High-Dose Chemotherapy with Autologous Stem Cell Transplant for Stage IV Breast Cancer with Minimal Metastatic Disease by NIETO, Y, CAGNONI, P. J, SHPALL, E. J, MATTHES, S, BARON, A, JONES, R. B, BEARMAN, S. I

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Nonpredictable Pharmacokinetic Behavior of High-Dose Cyclophosphamide in Combination with Cisplatin and 1,3-Bis(2-chloroethyl)-1-nitrosourea

    Nonpredictable Pharmacokinetic Behavior of High-Dose Cyclophosphamide in Combination with Cisplatin and 1,3-Bis(2-chloroethyl)-1-nitrosourea by NIETO, Y, XUESHENG XU, CAGNONI, P. J, MATTHES, S, SHPALL, E. J, BEARMAN, S. I, MURPHY, J, JONES, R. B

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer

    Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer by Nieto, Yago, Cagnoni, Pablo J., Bearman, Scott I., Shpall, Elizabeth J., Matthes, Steve, Jones, Roy B.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies

    Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory... by Nieto, Yago, Shpall, Elizabeth J., Bearman, Scott I., McSweeney, Peter A., Cagnoni, Pablo J., Matthes, Steve, Gustafson, Dan, Long, Michael, Barón, Anna E., Jones, Roy B.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors

    Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors by Andreassen, Ole A., Djurovic, Srdjan, Thompson, Wesley K., Schork, Andrew J., Kendler, Kenneth S., O’Donovan, Michael C., Rujescu, Dan, Werge, Thomas, van de Bunt, Martijn, Morris, Andrew P., McCarthy, Mark I., Roddey, J. Cooper, McEvoy, Linda K., Desikan, Rahul S., Dale, Anders M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Protect Your Practice, Protect Yourself, and Protect Your Family

    Protect Your Practice, Protect Yourself, and Protect Your Family by Bhatt, Nikhil J., Abaza, Mona M., Kelley, Kanwar S., Khalid, Ayesha N., Church, Steve, Matthes, William, Lee, K. J.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: